Triglycerides and amputation risk in patients with diabetes: Ten-year follow-up in the DISTANCE study

Diabetes Care

Volumn 34, Issue 3, 2011, Pages 635-640

  Callaghan, Brian C ^a   Feldman, Eva ^a   Liu, Jennifer ^b   Kerber, Kevin ^a   Pop Busui, Rodica ^a   Moffet, Howard ^b   Karter, Andrew J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ETHNICITY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH SURVEY; HOSPITAL DISCHARGE; HUMAN; HYPERTRIGLYCERIDEMIA; INCIDENCE; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; REFERENCE VALUE; RISK ASSESSMENT; SOCIAL STATUS;

AGED; AMPUTATION; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 79956074461     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0878     Document Type: Article

References (23)

1. Boulton AJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 2008;24(Suppl. 1):S3-S6 (Pubitemid 351802764)
2. van Houtum WH. Amputations and ulceration; pitfalls in assessing incidence. Diabetes Metab Res Rev 2008;24(Suppl. 1):S14-S18
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
5. Steiner G. How can we improve the management of vascular risk in type 2 diabetes: insights from FIELD. Cardiovasc Drugs Ther 2009;23:403-408
6. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393 (Pubitemid 36159355)
7. Tesfaye S, Chaturvedi N, Eaton SE, et al.; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350
8. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009;58:1634-1640
9. Humphrey AR, Dowse GK, Thoma K, Zimmet PZ. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention - a 12-year follow-up study in Nauru. Diabetes Care 1996;19:710-714
10. Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2006;49:2634-2641
11. Hiatt RA, Friedman GD. Characteristics of patients referred for treatment of end-stage renal disease in a defined population. Am J Public Health 1982;72:829-833
12. Selby JV. Linking automated databases for research in managed care settings. Ann Intern Med 1997;127:719-724 (Pubitemid 27446554)
13. Selby JV, Karter AJ, Ackerson LM, Ferrara A, Liu J.Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care 2001;24:1547-1555 (Pubitemid 33716447)
14. Karter AJ, Newman B, Rowell S, et al. Large-scale collection of family history data and recruitment of informative families for genetic analysis. J Registry Manag 1998;25:7-12
15. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA 2002;287:2519-2527 (Pubitemid 34517197)
16. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1-9 (Pubitemid 32635255)
17. Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care 1995;18:509-516
18. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998;68:899-917
19. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997;20:1162-1167
20. Christen WG, Manson JE, Bubes V, Glynn RJ; Sorbinil Retinopathy Trial Research Group. Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetesmellitus. Am J Epidemiol 1999;150:1142-1151
21. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med 1992;117:97-105
22. Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 2004;45:910-918 (Pubitemid 38868391)
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497